| Year |
Citation |
Score |
| 2019 |
Cocce KJ, Jasper JS, Desautels TK, Everett L, Wardell S, Westerling T, Baldi R, Wright TM, Tavares K, Yllanes A, Bae Y, Blitzer JT, Logsdon C, Rakiec DP, Ruddy DA, et al. The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer. Cell Reports. 29: 889-903.e10. PMID 31644911 DOI: 10.1016/J.Celrep.2019.09.032 |
0.399 |
|
| 2019 |
Westcott PMK, Pitkänen T, Blom S, Westerling T, Ropponen T, Sacks N, Wu K, Bronson R, Tammela T, Jacks T. Abstract 4447: Deep neural network for automatic histopathologic analysis of murine lung tumors Cancer Research. 79: 4447-4447. DOI: 10.1158/1538-7445.Am2019-4447 |
0.303 |
|
| 2018 |
Padilla-Rodriguez M, Parker SS, Adams DG, Westerling T, Puleo JI, Watson AW, Hill SM, Noon M, Gaudin R, Aaron J, Tong D, Roe DJ, Knudsen B, Mouneimne G. The actin cytoskeletal architecture of estrogen receptor positive breast cancer cells suppresses invasion. Nature Communications. 9: 2980. PMID 30061623 DOI: 10.1038/S41467-018-05367-2 |
0.44 |
|
| 2017 |
Cheng J, Park DE, Berrios C, White EA, Arora R, Yoon R, Branigan T, Xiao T, Westerling T, Federation A, Zeid R, Strober B, Swanson SK, Florens L, Bradner JE, et al. Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis. Plos Pathogens. 13: e1006668. PMID 29028833 DOI: 10.1371/Journal.Ppat.1006668 |
0.31 |
|
| 2017 |
Cato L, Neeb A, Sharp A, Buzón V, Ficarro SB, Yang L, Muhle-Goll C, Kuznik NC, Riisnaes R, Nava Rodrigues D, Armant O, Gourain V, Adelmant G, Ntim EA, Westerling T, et al. Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer. Elife. 6. PMID 28826504 DOI: 10.7554/Elife.27159 |
0.36 |
|
| 2017 |
Tavera-Mendoza LE, Westerling T, Libby E, Marusyk A, Cato L, Cassani R, Cameron LA, Ficarro SB, Marto JA, Klawitter J, Brown M. Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 28242709 DOI: 10.1073/Pnas.1615015114 |
0.387 |
|
| 2017 |
Cato L, Neeb A, Sharp A, Buzón V, Ficarro SB, Yang L, Muhle-Goll C, Kuznik NC, Riisnaes R, Rodrigues DN, Armant O, Gourain V, Adelmant G, Ntim EA, Westerling T, et al. Author response: Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer Elife. DOI: 10.7554/Elife.27159.041 |
0.396 |
|
| 2016 |
Elias KM, Emori MM, Westerling T, Long H, Budina-Kolomets A, Li F, MacDuffie E, Davis MR, Holman A, Lawney B, Freedman ML, Quackenbush J, Brown M, Drapkin R. Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors. Jci Insight. 1. PMID 27617304 DOI: 10.1172/Jci.Insight.87988 |
0.379 |
|
| 2016 |
Mounir Z, Korn JM, Westerling T, Lin F, Kirby CA, Schirle M, McAllister G, Hoffman G, Ramadan N, Hartung A, Feng Y, Kipp DR, Quinn C, Fodor M, Baird J, et al. ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the androgen receptor. Elife. 5. PMID 27183006 DOI: 10.7554/Elife.13964 |
0.404 |
|
| 2016 |
Mounir Z, Korn JM, Westerling T, Lin F, Kirby CA, Schirle M, McAllister G, Hoffman G, Ramadan N, Hartung A, Feng Y, Kipp DR, Quinn C, Fodor M, Baird J, et al. Author response: ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor Elife. DOI: 10.7554/Elife.13964.024 |
0.379 |
|
| 2015 |
Bailey ST, Westerling T, Brown M. Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer. Cancer Research. 75: 436-45. PMID 25388283 DOI: 10.1158/0008-5472.Can-14-1041 |
0.374 |
|
| 2015 |
Bailey ST, Westerling T, Brown M. Abstract LB-016: Estrogen receptor stability is modulated by calpain activity in breast cancer cells Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-016 |
0.436 |
|
| 2015 |
Cato L, Neeb A, Adelmant G, Ficarro S, Westerling T, Marto JA, Cato AC, Brown M. Abstract 4677: Control of androgen receptor function by the genomic action of the cochaperone Bag-1L Cancer Research. 75: 4677-4677. DOI: 10.1158/1538-7445.Am2015-4677 |
0.405 |
|
| 2014 |
Gordon FK, Vallaster CS, Westerling T, Iyer LK, Brown M, Schnitzler GR. Research resource: Aorta- and liver-specific ERα-binding patterns and gene regulation by estrogen. Molecular Endocrinology (Baltimore, Md.). 28: 1337-51. PMID 24992180 DOI: 10.1210/Me.2013-1395 |
0.372 |
|
| 2013 |
Tavera LE, Westerling T, Brown M. Abstract 3562: Genome-wide analysis of the vitamin D receptor (VDR) binding sites reveals vitamin D role modulating autophagy and metabolism in luminal-like breast cancer cells. Cancer Research. 73: 3562-3562. DOI: 10.1158/1538-7445.Am2013-3562 |
0.433 |
|
| 2012 |
Bailey ST, Shin H, Westerling T, Liu XS, Brown M. Estrogen receptor prevents p53-dependent apoptosis in breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: 18060-5. PMID 23077249 DOI: 10.1073/Pnas.1018858109 |
0.436 |
|
| 2012 |
Westerling T, Tavera-Mendoza L, Brown M. Abstract LB-406: Identification of functional enhancer SNPs in breast cancer models though ChIP-sequencing screening Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-406 |
0.412 |
|
| 2012 |
Tavera LE, Westerling T, Brown M. Abstract LB-275: Genome-wide analysis of the vitamin D receptor (VDR) binding sites reveals vitamin D role mediating autophagy in luminal-like breast cancer cells Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-275 |
0.437 |
|
| 2010 |
Lupien M, Meyer CA, Bailey ST, Eeckhoute J, Cook J, Westerling T, Zhang X, Carroll JS, Rhodes DR, Liu XS, Brown M. Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance. Genes & Development. 24: 2219-27. PMID 20889718 DOI: 10.1101/Gad.1944810 |
0.465 |
|
| Show low-probability matches. |